AzTrials
AzTrials

PTSDPhase 2/3NCT00622921

Couples-based Behavioral Psychotherapy for Male Patients With Posttraumatic Stress Disorder and Alcohol Dependence

A Phase 2/3 study testing Couples-based behavioral psychotherapy in people with PTSD and Alcohol Dependence, run by Yale University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Purpose: Phase I focus groups with clinicians and patients will gather qualitative data to focus and inform the content of Phase II. In Phase II, 12 weeks of psychotherapy will be offered to evaluate feasibility and potential efficacy of a couples-based, integrated treatment for men with PTSD and alcohol dependence. Read more about this study

Who is it for?
Ages 21 to 65 years, men only
Conditions the study is for
PTSD, Alcohol Dependence
What is being tested?
Couples-based behavioral psychotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Feb 2008to Feb 2012
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male patients
  • One to six weeks of abstinence from alcohol and other drugs
  • Both partners agree to stated goals of abstinence from alcohol and drugs, reduction of PTSD symptoms, and relationship improvement
  • Current diagnoses of both alcohol dependence and PTSD
  • Receiving treatment for one or both disorders
  • Functionally able to participate in outpatient treatment as determined by P.I. "Functionally able" includes access to transportation.
Show all 9Show fewer
  • Alcohol is "drug of choice" (History of other drugs acceptable)
  • Married or cohabiting in stable relationship for at least 6 months. Separated couples may participate if attempting to reconcile
  • Patient willing to sign release of information allowing researchers to communicate with patient's clinician regarding treatment goals

Who cannot join

  • Spouse or partner also has an alcohol or drug problem as determined by P.I. based on report by patient or partner or as revealed on Alcohol Use Disorders Identification Test (AUDIT) or the Drug Abuse Screening Test (DAST) given to partner at intake assessment
  • Mental retardation or learning disorder by clinician report or patient chart
  • Psychotic disorder as determined by patient's chart or SCID
  • Patient currently receiving methadone or another opiate agonist by patient report or chart
  • Current fear of partner or history of severe domestic violence in the past year. An example of severe violence would be a couple reporting an episode of violence that required medical attention. Such couples will be excluded from the study and referred to domestic violence treatment. Couples who have experienced mild to moderate domestic violence may participate in Phase II of the study.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA Connecticut Healthcare System

    West Haven, Connecticut, 06516

Other trials in United States

About this study

Purpose: Phase I focus groups with clinicians and patients will gather qualitative data to focus and inform the content of Phase II. In Phase II, 12 weeks of psychotherapy will be offered to evaluate feasibility and potential efficacy of a couples-based, integrated treatment for men with PTSD and alcohol dependence.

Hypotheses: We predict that this experimental psychotherapy, Partners Encouraging Abstinence and Coping with Emotions (PEACE), will reduce patient drinking, reduce PTSD symptoms, and improve relationship functioning.

Being tested
Couples-based behavioral psychotherapy
Keywords
PTSD, alcohol dependence
Medical subject headings
Stress Disorders, Post-Traumatic, Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Couples-based behavioral psychotherapyBehavioural

    12 weeks of Couples-based behavioral psychotherapy

Study groups in NCT00622921
Study groupRoleWhat they receive
1OtherCouples-based behavioral psychotherapy
Receives: Behavioral: Couples-based behavioral psychotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PTSD symptoms, Alcohol use

    Measured: 12 weeks

Secondary outcomes (1)
  1. relationship functioning

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2008 (estimated)
  2. Study startFeb 2008
  3. Primary completionFeb 2012 (estimated)
  4. Study completionFeb 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00622921
Sponsor's protocol ID
0711003228
Other IDs
0711003228
Status last verified
Mar 2020
First submitted
13 Feb 2008
Last updated
2 Apr 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Couples-based behavioral psychotherapy in people with PTSD and Alcohol Dependence, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 2 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PTSD symptoms, Alcohol use (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in